Task: Answer the multiple choice question.
Question: Which compound exhibits a 31.443% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1nc2ccc(S(=O)(=O)c3ccc4nc(C)[nH]c4c3)cc2[nH]1
b: C=CCNC(=S)N1CCN(S(=O)(=O)c2ccc(C)cc2)CC1
Answer: a. Cc1nc2ccc(S(=O)(=O)c3ccc4nc(C)[nH]c4c3)cc2[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc2ccc(S(=O)(=O)c3ccc4nc(C)[nH]c4c3)cc2[nH]1
Cc1nc2ccc(S(=O)(=O)c3ccc4nc(C)[nH]c4c3)cc2[nH]1
2-methyl-6-[(2-methyl-3H-benzimidazol-5-yl)sulfonyl]-1H-benzimidazole